Novartis (NYSE:NVS) Upgraded by StockNews.com to Strong-Buy Rating
Novartis (NYSE:NVS – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating ...
BioPharma Dive7h
Pfizer taps former Novartis exec to lead cancer drug push
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
Pharm Exec15h
Pfizer Appoints Jeffrey Legos as Chief Oncology Officer
Legos holds a PhD in physiology from Temple University and an MBA in finance from Villanova University. He has also written ...
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation ...
Who Will Be Advertising In Super Bowl LIX? Here’s A Partial List
The Super Bowl is only show where viewers actually look forward to the ads. At a price tage of at least $7 million for :30.
MM&M9h
Bayer’s Super Bowl ad tackles denial in heart disease
In the latest iteration of See Your Risks, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart ...